Opportunity Information: Apply for PA 08 209
Apply for PA 08 209
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "PPilot studies in Pancreatic Cancer (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control.
- This funding opportunity was created on Dec 5, 2008 and posted on Jul 18, 2008.
- Applicants must submit their applications by Sep 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses State governments Private institutions of higher education.
- Other Eligible Applicants include the following Eligible Agencies of the Federal Government Hispanic serving Institutions Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The PPilot studies in Pancreatic Cancer (R03) opportunity (Funding Opportunity Number PA 08 209) is a National Cancer Institute (NCI) funding announcement under the National Institutes of Health (NIH) that focuses on advancing pancreatic cancer research through small, fast-moving projects. Its main goal is to spark innovative, cross-disciplinary work that improves understanding of pancreatic cancer biology and origins (etiology), and that supports progress in detection, prevention, and treatment. In practice, the program is meant to help researchers generate early evidence, explore promising ideas, or develop tools that can later be scaled into larger studies.
This announcement uses the NIH Small Research Grant (R03) mechanism, which is specifically designed for projects that are limited in scope and can be completed in a relatively short time with modest resources. The types of studies encouraged are broad but share a common theme of being tightly focused and feasible. Examples include pilot and feasibility studies that test a new concept or approach, secondary analyses of existing datasets (for instance, reanalyzing clinical, imaging, genomic, or population data to uncover new signals), small self-contained research efforts that answer a focused question, and the development of research methods or new technologies that could improve how pancreatic cancer is studied, detected, or treated.
The FOA also notes that it runs in parallel with another announcement of the same scientific scope that uses a different mechanism: an R21 opportunity (PA 08 208). The inclusion of this detail matters because it signals that applicants with similar scientific aims may have two distinct routes depending on the maturity and needs of the project, with the R03 emphasizing smaller, quicker projects and limited budgets.
Funding levels and the number of awards are not set as fixed totals in the announcement. Instead, NIH indicates that award size, duration, and the number of grants made will vary depending on the applications received, including their scientific merit, proposed project period, and requested budgets. In other words, there is no guaranteed award count; awards depend on the pool of submissions and available funds during the relevant cycles.
Eligibility is broad and includes many organization types. Eligible applicants include public and private institutions of higher education, nonprofit organizations (both with and without 501(c)(3) status, as described), for-profit organizations (other than small businesses), small businesses, and state governments. The eligibility list also extends to certain additional categories, including eligible federal agencies, Hispanic-serving institutions, non-U.S. entities (foreign organizations), regional organizations, and U.S. territories or possessions. The announcement states there is no cost-sharing or matching requirement, which means applicants are not required to contribute a specific amount of non-federal funds to be eligible.
From an administrative standpoint, this is a discretionary grant opportunity in the health and education-related research space, mapped to multiple cancer-related CFDA numbers covering prevention, detection and diagnosis, treatment, biology, and control. The opportunity was posted July 18, 2008, and ultimately closed on September 7, 2011, with an archive date of October 8, 2011. Applicants seeking the original full text were directed to the NIH Grants Guide page for PA 08 209, and technical access issues were handled through the NIH Office of Extramural Research (OER) webmaster contact.
Frequently Asked Questions (FAQs): Pilot Studies in Pancreatic Cancer (R03) - PA-08-209
1) What is the Pilot Studies in Pancreatic Cancer (R03) opportunity (PA-08-209)?
PA-08-209 is a National Cancer Institute (NCI) funding announcement under the National Institutes of Health (NIH) that supports pilot, feasibility, and other small, fast-moving research projects focused on pancreatic cancer.
2) Which NIH grant mechanism does this opportunity use?
This opportunity uses the NIH Small Research Grant (R03) mechanism, which is intended for research projects that are limited in scope and can be completed in a relatively short time with modest resources.
3) What is the main purpose of this FOA?
The purpose is to advance pancreatic cancer research by sparking innovative, cross-disciplinary projects that improve understanding of pancreatic cancer biology and origins (etiology), and that support progress in detection, prevention, and treatment.
4) What kinds of projects are encouraged under this R03 announcement?
The FOA encourages tightly focused, feasible studies that can generate early evidence, explore promising new ideas, or develop tools that could later be scaled into larger studies.
5) Are pilot and feasibility studies appropriate for this opportunity?
Yes. Pilot and feasibility studies that test a new concept or approach are specifically listed as examples of the types of studies encouraged.
6) Can applicants propose secondary analysis of existing data?
Yes. The FOA encourages secondary analyses of existing datasets, including reanalysis of clinical, imaging, genomic, or population data to identify new signals or insights relevant to pancreatic cancer.
7) Does the FOA support small, self-contained research efforts?
Yes. Small, self-contained research efforts that answer a focused question are included among the encouraged project types.
8) Does this announcement allow method development or new technology development?
Yes. The development of research methods or new technologies that could improve how pancreatic cancer is studied, detected, or treated is identified as an appropriate project type.
9) Is this funding opportunity limited to one discipline?
No. The FOA explicitly emphasizes innovative, cross-disciplinary work.
10) What scientific areas within pancreatic cancer does the FOA aim to advance?
The FOA highlights improving understanding of pancreatic cancer biology and etiology, and supporting progress in detection, prevention, and treatment.
11) How does PA-08-209 relate to the R21 announcement PA-08-208?
The FOA notes that it runs in parallel with PA-08-208, an R21 opportunity with the same scientific scope but a different funding mechanism. This indicates there are two potential routes depending on the project needs, with the R03 emphasizing smaller, quicker projects with limited budgets.
12) Are the number of awards and total funding amounts fixed?
No. The announcement does not set a fixed total number of awards or a fixed overall funding level. NIH indicates that award size, duration, and the number of grants made will vary based on the applications received, their scientific merit, the proposed project period, and requested budgets.
13) Is there a guaranteed number of grants that will be awarded?
No. Awards are dependent on the pool of submissions and available funds during the relevant cycles.
14) What types of organizations are eligible to apply?
Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status as described), for-profit organizations (other than small businesses), small businesses, and state governments.
15) Are federal agencies eligible applicants?
Yes. The eligibility list includes eligible federal agencies.
16) Are Hispanic-serving institutions eligible?
Yes. Hispanic-serving institutions are included in the eligibility list.
17) Can non-U.S. organizations (foreign organizations) apply?
Yes. The eligibility list includes non-U.S. entities (foreign organizations).
18) Are U.S. territories or possessions eligible to apply?
Yes. U.S. territories or possessions are included among eligible applicants.
19) Are regional organizations eligible under this FOA?
Yes. Regional organizations are listed as eligible applicants.
20) Is cost sharing or matching required?
No. The announcement states there is no cost-sharing or matching requirement.
21) What kind of grant is this from an administrative standpoint?
It is described as a discretionary grant opportunity in the health and education-related research space.
22) Which agency and institute sponsor this funding announcement?
This is an NIH funding announcement sponsored by the National Cancer Institute (NCI).
23) What CFDA areas does this opportunity map to?
The opportunity is mapped to multiple cancer-related CFDA numbers covering prevention, detection and diagnosis, treatment, biology, and control.
24) When was this opportunity posted?
The opportunity was posted on July 18, 2008.
25) When did the opportunity close?
The opportunity closed on September 7, 2011.
26) When was the archive date for this announcement?
The archive date listed is October 8, 2011.
27) Where were applicants directed to find the original full text of the announcement?
Applicants were directed to the NIH Grants Guide page for PA-08-209 for the original full text.
28) Who handles technical access issues related to the announcement?
Technical access issues were handled through the NIH Office of Extramural Research (OER) webmaster contact.
Browse more opportunities from the same category: Education Health
Next opportunity: Diet Induced Changes in Inflammation as Determinants of Colon Cancer (R01)
Previous opportunity: Pilot studies in Pancreatic Cancer (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 08 209
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 08 209) also looked into and applied for these:
| Funding Opportunity |
|---|
| Diet Induced Changes in Inflammation as Determinants of Colon Cancer (R01) Apply for PA 08 210 Funding Number: PA 08 210 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Diet Induced Changes in Inflammation as Determinants of Colon Cancer (R21) Apply for PA 08 211 Funding Number: PA 08 211 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Drug Abuse Prevention Intervention Research (R01) Apply for PA 08 217 Funding Number: PA 08 217 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Prevention Intervention Research (R21) Apply for PA 08 218 Funding Number: PA 08 218 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Drug Abuse Prevention Intervention Research (R03) Apply for PA 08 219 Funding Number: PA 08 219 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Investigational Nutrigenetic Studies for Cancer Prevention (R01) Apply for PA 08 220 Funding Number: PA 08 220 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Investigational Nutrigenetic Studies for Cancer Prevention (R21) Apply for PA 08 221 Funding Number: PA 08 221 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Etiology, Prevention, and Treatment of Hepatocellular Carcinoma(R21) Apply for PA 08 244 Funding Number: PA 08 244 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R03) Apply for RFA DA 09 019 Funding Number: RFA DA 09 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R01) Apply for RFA DA 09 017 Funding Number: RFA DA 09 017 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Physical Science Oncology Centers (U54) Apply for RFA CA 09 009 Funding Number: RFA CA 09 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,250,000 |
| NINR Mentored Research Scientist Development Award for Underrepresented or Disadvantaged Investigators (K01) Apply for PAR 05 135 Funding Number: PAR 05 135 Agency: National Institutes of Health Category: Education Health Funding Amount: $20,000 |
| NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 08 047 Funding Number: PAR 08 047 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NINR Career Transition Award (K22) Apply for PAR 08 148 Funding Number: PAR 08 148 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on the Cognitive Sequelae of Parkinsons Disease (R01) Apply for PA 09 033 Funding Number: PA 09 033 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Established Investigator Award in Cancer Prevention and Control Apply for PAR 05 145 Funding Number: PAR 05 145 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Career Development Award to Promote Diversity (K01) Apply for PAR 06 220 Funding Number: PAR 06 220 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Mentored Clinical Scientist Award to Promote Diversity (K08) Apply for PAR 06 221 Funding Number: PAR 06 221 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mentored Patient Oriented Research Award to Promote Diversity (K23) Apply for PAR 06 222 Funding Number: PAR 06 222 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Building Translational Research in Integrative Behavioral Science (R24) Apply for PAR 06 357 Funding Number: PAR 06 357 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 209", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.